Long Island Business News
October 14, 2013
North Shore-LIJ converting closed King Kullen
The North Shore-Long Island Jewish Health System plans to convert a closed King Kullen supermarket in Bay Shore into a health care facility.
The system has submitted a request to the state to approve the $37 million project to turn 46,000 square feet of the closed store into an outpatient facility focusing on radiation and medical oncology and imaging.
“It’s a continuing expansion of our outpatient cancer services,” North Shore-LIJ spokesman Terry Lynam said.
He said the system hopes to finish the project in 2014, although the start of construction is contingent on state approval.
North Shore-LIJ already has been expanding outpatient cancer services at its Center for Advanced Medicine in New Hyde Park, which includes the Monter Cancer Center, home to North Shore University Hospital’s hematology oncology program.
Crain's Health Pulse
October 15, 2013
Cancer Facility Proposed for Bay Shore
For Long Islanders shopping for cancer treatment options closer to home, the site of a former King Kullen grocery store could be one alternative. North Shore-LIJ filed a certificate-of-need application to turn a Bay Shore, L.I., vacant store into an outpatient facility for radiation oncology services.
The $34 million project is for a site at 440 E. Main St. The system plans to lease 39,731 square feet of the property for its North Shore-LIJ Cancer Institute. The system filed a CON for the following: CT scanner, linear accelerator, nuclear medicine, PET scanner, primary care, radiology (diagnostic and therapeutic), and outpatient surgery.
Construction is projected to begin in the spring of 2014 if the application is approved. The facility should be operational in early 2015.
North Shore-LIJ announced earlier this year that it would spend $175 million to expand its cancer services, open new cancer treatment centers and make the North Shore-LIJ Cancer Institute a systemwide cancer care brand. The system historically has delivered cancer services at its individual hospitals and via affiliated community-based physicians. The Cancer Institute’s market share is 11.9% of all medical-surgical discharges of cancer patients in the New York area and 15.4% of all oncology surgeries, according to the system.